[1]
Corona Prandi , B., P Rosim, M., Ogata Pedro, G. e Papadimitropoulos, M. 2023. Cost per number needed to treat and treatment cost of baricitinib versus adalimumab on rheumatoid arthritis treatment in the brazilian private healthcare system . JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA. 4, s.1 (fev. 2023). DOI:https://doi.org/10.22563/2525-7323.2019.v4.s1.p.117.